What accounts for the association between late preterm births and risk of asthma?

Insights

Late preterm (LPT) infants do not have an increased risk of asthma. Maternal smoking during pregnancy is a significant risk factor for childhood asthma development.

Area of Science:

  • Pediatric Pulmonology
  • Neonatal Health
  • Epidemiology

Background:

  • Previous studies suggested an increased asthma risk in late preterm (LPT) infants.
  • Many studies did not adequately address covariate imbalance, potentially biasing results.

Purpose of the Study:

  • To compare asthma incidence in LPT infants versus matched term infants.
  • To account for covariate imbalance in assessing LPT birth and asthma risk.

Main Methods:

  • Population-based cohort study of LPT and term infants (born 2002-2006).
  • Follow-up through 2010 with asthma status determined by predefined criteria.
  • Kaplan-Meier and Cox models used to analyze cumulative incidence and adjust for confounders.

Main Results:

  • LPT infants showed a higher unadjusted asthma frequency (29.9%) than term infants (19.5%).
  • After adjusting for covariates, LPT birth was not associated with increased asthma risk.
  • Maternal smoking during pregnancy was identified as a significant risk factor for asthma.

Conclusions:

  • Late preterm birth is not an independent risk factor for asthma.
  • Reducing maternal smoking during pregnancy is crucial for mitigating asthma risk in children.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.4K